Monsanto ally Novozymes sees opportunity, risk in Bayer merger

By Ben Hirschler LONDON (Reuters) - Novozymes, already grappling with the consequences of low oil and crop prices, is watching anxiously to see what Bayer's purchase of Monsanto will mean for the Danish group's ties with its key agricultural partner. Chief Executive Peder Holk Nielsen said in an interview that a merged Bayer-Monsanto could extend the market for the company's smart microbial crop-boosting products, known as inoculants, but added the union also brings uncertainties. "But we think